This policy applies to activities that involve the secondary analysis of data (such as medical records, student records, data collected from previous studies, audio/video recordings, etc.) or ...
Useful aspects of submitted secondary pharmacology data. Detailed aspects of secondary pharmacology data that are considered to be useful during regulatory safety assessments are summarized in Table 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results